<DOC>
	<DOC>NCT02088411</DOC>
	<brief_summary>The aim of this randomized, double-blind, placebo-controlled, comparator-controlled trial was to evaluate the safety and efficacy of an enzyme combination, as WobenzymÂ®, in adults with moderate-to-severe osteoarthritis (OA) of the knee.</brief_summary>
	<brief_title>The Safety and Efficacy of an Enzyme Combination in Managing Knee Osteoarthritis Pain in Adults</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Wobenzym</mesh_term>
	<criteria>Knee osteoarthritis confirmed by radiography or tomography Lequesne Functional Index score of 1014 WOMACA pain subscale score greater than or equal to 25 History of knee trauma History of joint infection History of joint surgery History of intraarticular injection (viscotherapy) History of gastrointestinal diseases Use of corticosteroids Use of COXII inhibitors Use of glucosamine/chondroitin Known sensitivity to paracetamol Known sensitivity to nonsteroidal antiinflammatory drugs (NSAIDs) Known sensitivity to oral enzymes</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>